Assenagon Asset Management S.A. Decreases Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Assenagon Asset Management S.A. cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 28.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 230,924 shares of the medical device company's stock after selling 93,058 shares during the period. Assenagon Asset Management S.A. owned about 0.12% of Cooper Companies worth $21,229,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. Wedmont Private Capital increased its stake in Cooper Companies by 16.2% during the fourth quarter. Wedmont Private Capital now owns 4,854 shares of the medical device company's stock worth $438,000 after acquiring an additional 676 shares during the last quarter. Czech National Bank increased its position in shares of Cooper Companies by 6.5% during the 4th quarter. Czech National Bank now owns 43,181 shares of the medical device company's stock valued at $3,970,000 after purchasing an additional 2,619 shares during the last quarter. Graypoint LLC raised its holdings in Cooper Companies by 205.9% during the 4th quarter. Graypoint LLC now owns 6,458 shares of the medical device company's stock valued at $594,000 after buying an additional 4,347 shares during the period. Fulton Bank N.A. lifted its position in Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock worth $342,000 after buying an additional 109 shares during the last quarter. Finally, GAMMA Investing LLC boosted its stake in Cooper Companies by 9.2% during the fourth quarter. GAMMA Investing LLC now owns 3,605 shares of the medical device company's stock worth $331,000 after buying an additional 304 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

COO has been the subject of several analyst reports. StockNews.com lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Morgan Stanley cut their target price on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Friday, December 6th. Citigroup decreased their price target on Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a research note on Friday, December 6th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Wells Fargo & Company boosted their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, December 6th. Four equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat.com, Cooper Companies has a consensus rating of "Moderate Buy" and an average price target of $117.00.

Cooper Companies Stock Up 1.3 %

Cooper Companies stock traded up $1.23 during mid-day trading on Friday, reaching $93.27. 1,950,968 shares of the company were exchanged, compared to its average volume of 1,071,215. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market cap of $18.61 billion, a P/E ratio of 47.83, a PEG ratio of 2.29 and a beta of 0.99. The business has a fifty day moving average of $96.54 and a 200 day moving average of $98.89. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping analysts' consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.03 billion. During the same period in the prior year, the business posted $0.87 EPS. The firm's quarterly revenue was up 9.8% on a year-over-year basis. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.